United States · 
What does Deerfield invest in?
Deerfield invests most often at Venture and Series A (51% of the rounds on record), in sectors such as Healthcare.
Deerfield highlights
- 01
17 cheques in the last 12 months
- 02
Mostly Venture and Series A: 51% of its rounds
- 03
Sole investor in 55 rounds, median $50M
- 04
5 exits from the portfolio
What they do
We work across the healthcare ecosystem to build companies independently and with strategic partners.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- Healthcare
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first198 appearances
- 2026
13 rounds
- Oct
- Sept
- Aug
- May
- Apr
- Apr
- Apr
- Apr
- Apr
- Apr
- Mar
- Feb
- Jan
- 2025
23 rounds
- Dec
- DecBIOMx$3.0MWith 3 others
- Dec
- Nov
- Oct
- Oct
- Oct
- Sept
- Sept
- Aug
- Jun
- Jun
- May
- May
- May
- Apr
- Apr
- Mar
- Mar
- Feb
- Feb
- Jan
- Jan
- 2024
20 rounds
- Dec
- Nov
- Nov
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
ACAlexis CazéChief Operating OfficeriForm ADV
BSBryan Scott SendrowskiChief Financial OfficeriForm ADV
DJDavid Justus ClarkGeneral CounseliForm ADV
GEGraham E. CookDirectoriFiling they signed
JEJames Edward FlynnPresident of J.E. Flynn Capital, LLC, the General Partner of Deerfield Capital, L.P., the General PartneriFiling they signed
JDJonathan David IslerChief Financial Officer, FundsiForm ADV
NLNicholas LaneDirectoriFiling they signed
PEPeter E. YoungDirectoriFiling they signed
RTRobert Todd SnetikerChief Compliance OfficeriForm ADV
We also hold 97 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$19Bassets it managesOct 2026
21+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Deerfield Management Company, L.P.
- SEC number
- CRD 157876
Funds on its Form ADV
11 private funds, $16B in gross assets · filed Mar 2024
Hedge 10Private equity 1
- Deerfield Partners, L.P.Hedge171 investors$6.2B
- Deerfield Private Design Fund IV, L.P.Hedge203 investors$3.7B
- Deerfield Private Design Fund III, L.P.Hedge152 investors$1.8B
- Deerfield Healthcare Innovations Fund, L.P.Hedge124 investors$1.5B
- Deerfield Private Design Fund V, L.P.Hedge95 investors$1.5B
- Deerfield Healthcare Innovations Fund II, L.P.Hedge96 investors$882M
- Deerfield Healthcare Innovations Fund III, L.P.Hedge36 investors$334M
- Deerfield Private Design Fund II, L.P.Hedge62 investors$118M
- Deerfield Private Design International II, L.P.Hedge42 investors$113M
- Deerfield PDI Financing II, L.P.Private equity42 investors$22M
And 1 more on the filing.
Exits from the portfolio
Companies it backed that were later bought or listed5 in all
Auspex PharmaceuticalsBought by Teva Pharmaceutical Industries$3.2BMar 2015
Foundation MedicineBought by RocheUndisclosedJan 2015
Foundation MedicineListed$108MJul 2013
TengionListedUndisclosedApr 2010
Third Wave TechnologiesBought by Hologic$567MJun 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.